DIN 02505851 — LUXTURNA 5000000000000 VG
LUXTURNA is a solution of Voretigene neparvovec marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Voretigene neparvovec monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02505851
- Brand name
- LUXTURNA
- Active ingredient
- Voretigene neparvovec
- Strength
- 5000000000000 VG
- Dosage form
- SOLUTION
- Route
- SUBRETINAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Adeno-associated virus (AAV2) vector-based gene therapy
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.